The Magazine for Sleep Professionals
Monday, April 6, 2026
Positioned at the forefront of helping people with obstructive sleep apnea (OSA) improve their health and quality of life, AR Medical Technologies launches MaskFit AR. Powered by artificial intelligence and machine learning, MaskFit AR overcomes a 30-year problem of improper patient mask fitment for people who use CPAP or BiPAPTM to […]
Apnimed, a clinical-stage pharmaceutical company focused on developing oral medicines to treat Obstructive Sleep Apnea (OSA) and related disorders, today announced that the first patient has been dosed in a Phase 2 clinical trial evaluating AD109 as a treatment for mild to moderate OSA. If successful, AD109 could offer an […]
Introduction Sleep apnea, with an estimated incidence between three and seven percent in the general population, is a common disorder.1 Currently, either an at-home sleep test or overnight polysomnographic test is necessary to diagnose sleep apnea. Both of these evaluations are at times cumbersome. Consequently, patients may be unwilling to […]
Older adults with undiagnosed obstructive sleep apnea seek more health care, according to a study published in the January issue of the Journal of Clinical Sleep Medicine. The study examined the impact of untreated sleep apnea on health care utilization and costs among Medicare beneficiaries. The authors reviewed a sample of Medicare […]
By Matthew Anastasi, BS, RST, RPSGT Located in the tiny village of Merida, Venezuela is Heladería Coromoto, an ice cream parlor, known for offering a Guinness Record for most flavors of ice cream in the world (860 varieties). Despite our sometimes homogeneous view of the condition, sleep-disordered breathing (SDB) has […]
A research team led by the University of Minnesota Morris found that a trucking firm that mandated treatment for its drivers with obstructive sleep apnea (OSA) saved significantly on non-OSA-program medical insurance costs. Despite evidence that untreated OSA is associated with significantly higher rates of serious preventable truck crashes, the U.S. Department […]
It is with the utmost respect that we announce the passing of Dr. Christian Guilleminault July 9, 2019, in Palo Alto, CA, from metastatic cancer. Guilleminault was surrounded by family, colleagues, and fellows during his final days. The messages and outreach from across the globe have been overwhelming this past […]
Masimo has announced the findings of a recently published study in which researchers investigated whether home pulse oximetry monitoring might be a useful initial screening method of determining which children with Down syndrome (DS) – who are at high risk of obstructive sleep apnea (OSA) – be recommended to undergo […]
Therapix Biosciences Ltd., a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced that on June 05, 2018, the first subject was enrolled for its Phase IIa, sponsor-initiated clinical trial using the Company’s cannabinoid-based technology THX-110 for Obstructive Sleep Apnea (OSA), at Assuta Medical Center, the largest […]
Researchers analyzed prevalence studies from 16 countries, together with data from the World Health Organization and United Nations World Population Prospects A new data analysis presented by ResMed this week at the ATS 2018 International Conference indicates that the prevalence of sleep apnea impacts more than 936 million people worldwide […]
